Found: 4
Select item for more details and to access through your institution.
Metabolite profiling of foslevodopa/foscarbidopa in plasma of healthy human participants by LC‐HRMS indicates no major differences compared to administration of levodopa/carbidopa intestinal gel.
- Published in:
- Pharmacology Research & Perspectives, 2024, v. 12, n. 2, p. 1, doi. 10.1002/prp2.1190
- By:
- Publication type:
- Article
Bioequivalence of Elagolix/Estradiol/Norethindrone Acetate Fixed‐Dose Combination Product: Phase 1 Results in Healthy Pre‐ and Postmenopausal Women.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 6, p. 601, doi. 10.1002/cpdd.1399
- By:
- Publication type:
- Article
Comparability of Foslevodopa/Foscarbidopa Pharmacokinetics in Healthy Asian and White Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 4, p. 407, doi. 10.1002/cpdd.1201
- By:
- Publication type:
- Article
A Phase-I pharmacokinetic, safety and food-effect study on flubentylosin, a novel analog of Tylosin-A having potent anti-Wolbachia and antifilarial activity.
- Published in:
- PLoS Neglected Tropical Diseases, 2023, v. 17, n. 7, p. 1, doi. 10.1371/journal.pntd.0011392
- By:
- Publication type:
- Article